Results 121 to 130 of about 27,022 (204)

The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma. [PDF]

open access: yesBlood Cancer J
Xu J   +13 more
europepmc   +1 more source

FcεRIγ reinforces double-negative T cell-mediated antibody-dependent cellular cytotoxicity against tumor cells. [PDF]

open access: yesJ Mol Cell Biol
Shao S   +13 more
europepmc   +1 more source

Functional antibody responses and protection against symptomatic dengue. [PDF]

open access: yesCommun Med (Lond)
Chua CLL   +5 more
europepmc   +1 more source

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas. [PDF]

open access: yesBr J Haematol
Neumann F   +13 more
europepmc   +1 more source

Longitudinal assessment of functional antibodies to a novel influenza virus strain across age groups. [PDF]

open access: yesPLoS Pathog
Huckriede A   +6 more
europepmc   +1 more source

Tumor Acidosis Boosts Antibody-Driven Cytotoxic Potential of Neutrophils. [PDF]

open access: yesCells
Holtrop T   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy